Manuel E. Kaplan

2.8k total citations · 1 hit paper
53 papers, 2.3k citations indexed

About

Manuel E. Kaplan is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Manuel E. Kaplan has authored 53 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 15 papers in Genetics and 14 papers in Immunology. Recurrent topics in Manuel E. Kaplan's work include Blood groups and transfusion (12 papers), Erythrocyte Function and Pathophysiology (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Manuel E. Kaplan is often cited by papers focused on Blood groups and transfusion (12 papers), Erythrocyte Function and Pathophysiology (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Manuel E. Kaplan collaborates with scholars based in United States, Israel and United Kingdom. Manuel E. Kaplan's co-authors include Martin M. Oken, Jorge J. Yunis, Athanasios Theologides, James H. Jandl, Kathy M. Ensrud, Louis R. Wasserman, Karen Mack, B J Gormus, P D Berk and Elvin A. Kabat and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.

In The Last Decade

Manuel E. Kaplan

51 papers receiving 2.1k citations

Hit Papers

Distinctive Chromosomal Abnormalities in Histologic Subty... 1982 2026 1996 2011 1982 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel E. Kaplan United States 25 944 786 562 543 473 53 2.3k
F. G. J. Hayhoe United Kingdom 30 1.0k 1.1× 1.3k 1.6× 678 1.2× 957 1.8× 887 1.9× 114 3.5k
Pierre Stryckmans Belgium 26 827 0.9× 1.1k 1.4× 382 0.7× 750 1.4× 558 1.2× 97 2.5k
KB McCredie United States 26 1.2k 1.2× 1.7k 2.1× 421 0.7× 566 1.0× 561 1.2× 60 2.8k
K. Ganeshaguru United Kingdom 36 1.2k 1.2× 915 1.2× 433 0.8× 1.4k 2.6× 830 1.8× 84 3.3k
B. Grosbois France 26 780 0.8× 1.2k 1.5× 328 0.6× 1.3k 2.4× 223 0.5× 118 2.6k
D. A. G. Galton United Kingdom 30 1.9k 2.0× 2.1k 2.7× 1.0k 1.8× 862 1.6× 1.3k 2.7× 65 4.7k
Paul A. Chervenick United States 21 366 0.4× 665 0.8× 157 0.3× 254 0.5× 493 1.0× 40 1.7k
R Mertelsmann Germany 26 359 0.4× 868 1.1× 296 0.5× 533 1.0× 1.2k 2.5× 70 2.6k
M Tulliez France 28 1.4k 1.4× 1.1k 1.4× 1.0k 1.8× 860 1.6× 396 0.8× 85 4.0k
Carlos Richard Spain 24 526 0.6× 762 1.0× 164 0.3× 730 1.3× 390 0.8× 70 2.2k

Countries citing papers authored by Manuel E. Kaplan

Since Specialization
Citations

This map shows the geographic impact of Manuel E. Kaplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel E. Kaplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel E. Kaplan more than expected).

Fields of papers citing papers by Manuel E. Kaplan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel E. Kaplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel E. Kaplan. The network helps show where Manuel E. Kaplan may publish in the future.

Co-authorship network of co-authors of Manuel E. Kaplan

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel E. Kaplan. A scholar is included among the top collaborators of Manuel E. Kaplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel E. Kaplan. Manuel E. Kaplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaplan, Manuel E. & James H. Jandl. (2015). Immune Hemolysis in Man: The Effects of Antiglobulins and Rheumatoid Factors. Proceedings of the International Society of Blood Transfusion. 19. 375–380.
2.
Fruchtman, Steven, Karen Mack, Manuel E. Kaplan, et al.. (1997). From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera.. PubMed. 34(1). 17–23. 177 indexed citations
3.
Brubaker, Leonard H., Louis R. Wasserman, Judith D. Goldberg, et al.. (1984). Increased prevalence of polycythemia vera in parents of patients on polycythemia vera study group protocols. American Journal of Hematology. 16(4). 367–373. 12 indexed citations
4.
Donovan, Paul B., Manuel E. Kaplan, Judith D. Goldberg, et al.. (1984). Treatment of polycythemia vera with hydroxyurea. American Journal of Hematology. 17(4). 329–334. 81 indexed citations
5.
Zanjani, Esmail D., et al.. (1982). In vitro suppression of erythropoiesis by bone marrow adherent cells from some patients with fungal infection. British Journal of Haematology. 50(3). 479–490. 10 indexed citations
6.
Roodman, G. David, Joel M. Kaplan, Manuel E. Kaplan, & ED Zanjani. (1981). Effects of Shortened Erythropoietin Exposure on Sheep Marrow Cultures. British Journal of Haematology. 47(2). 195–201. 4 indexed citations
7.
Gormus, B J, Michael L. Basara, Martin M. Oken, Stephen H. Leech, & Manuel E. Kaplan. (1981). Capping of peripheral blood lymphocyte C3 receptors in chronic lymphocytic leukemia: Relationship to chemotherapy. International Journal of Cancer. 27(2). 151–159. 3 indexed citations
9.
Johnson, Gerhard J., David W. Allen, Virgil F. Fairbanks, et al.. (1979). Red-Cell-Membrane Polypeptide Aggregates in Glucose-6-Phosphate Dehydrogenase Mutants with Chronic Hemolytic Disease. New England Journal of Medicine. 301(10). 522–527. 76 indexed citations
10.
Vessella, Robert L., Paul H. Lange, B J Gormus, & Manuel E. Kaplan. (1978). Heterogeneity among human lymphocyte effector cells mediating spontaneous lymphocyte‐mediated cytotoxicity. International Journal of Cancer. 21(5). 594–603. 21 indexed citations
11.
Zak, Solomon J., Bernadine Brimhall, Richard T. Jones, & Manuel E. Kaplan. (1974). Hemoglobin Andrew-Minneapolis αA2β144 Lys → Asn2: A New High-Oxygen-Affinity Mutant Human Hemoglobin. Blood. 44(4). 543–549. 32 indexed citations
12.
Sherman, Laurence A., et al.. (1972). Fibrinogen St. Louis: A New Inherited Fibrinogen Variant, Coincidentally Associated with Hemophilia A. Journal of Clinical Investigation. 51(3). 590–597. 21 indexed citations
13.
Kaplan, Manuel E., et al.. (1972). Complement-Dependent Opsonization of Incompatible Erythrocytes by Human Secretory IgA. The Journal of Immunology. 108(1). 275–278. 30 indexed citations
14.
Kaplan, Manuel E.. (1968). Cryoglobulinemia in infectious mononucleosis: quantitation and characterization of the cryoproeins.. PubMed. 71(5). 754–65. 46 indexed citations
15.
Kaplan, Manuel E., et al.. (1966). Serum Anti-γG Globulin Factors in Paroxysmal Nocturnal Hemoglobinuria. Blood. 28(3). 446–454. 3 indexed citations
16.
Kaplan, Manuel E. & Elvin A. Kabat. (1966). STUDIES ON HUMAN ANTIBODIES. The Journal of Experimental Medicine. 123(6). 1061–1081. 78 indexed citations
17.
Smith, Alfred A., et al.. (1964). Dehydroxylation of some catecholamines and their products. Biochimica et Biophysica Acta (BBA) - General Subjects. 86(3). 429–437. 9 indexed citations
18.
Kaplan, Manuel E. & James H. Jandl. (1963). THE EFFECT OF RHEUMATOID FACTORS AND OF ANTIGLOBULINS ON IMMUNE HEMOLYSIS IN VIVO. The Journal of Experimental Medicine. 117(1). 105–125. 22 indexed citations
19.
Kaplan, Manuel E. & James H. Jandl. (1961). INHIBITION OF RED CELL SEQUESTRATION BY CORTISONE. The Journal of Experimental Medicine. 114(6). 921–937. 31 indexed citations
20.
Jandl, James H. & Manuel E. Kaplan. (1960). THE DESTRUCTION OF RED CELLS BY ANTIBODIES IN MAN. III. QUANTITATIVE FACTORS INFLUENCING THE PATTERNS OF HEMOLYSIS IN VIVO*. Journal of Clinical Investigation. 39(7). 1145–1156. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026